Global Adipose Tissue-derived Stem Cell Therapy Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Adipose Tissue-derived Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Adipose Tissue-derived Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Adipose Tissue-derived Stem Cell Therapy market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Adipose Tissue-derived Stem Cell Therapy market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Adipose Tissue-derived Stem Cell Therapy, covering the supply chain analysis, impact assessment to the Adipose Tissue-derived Stem Cell Therapy market size growth rate in several scenarios, and the measures to be undertaken by Adipose Tissue-derived Stem Cell Therapy companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Autologous Stem Cells
Allogeneic Stem Cells
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Therapeutic Application
Research Application
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AlloCure
Tissue Genesis
Antria
Cellleris
Corestem
Celgene Corporation
Mesoblast
Cytori Therapeutics
Pluristem Therapeutics
Intrexon
Lonza
BioRestorative Therapies
Pluristem Therapeutics
iXCells Biotechnologies
Cyagen
Celltex Therapeutics Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Adipose Tissue-derived Stem Cell Therapy market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Adipose Tissue-derived Stem Cell Therapy market by identifying its various subsegments.
Focuses on the key global Adipose Tissue-derived Stem Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Adipose Tissue-derived Stem Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Adipose Tissue-derived Stem Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Adipose Tissue-derived Stem Cell Therapy?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Adipose Tissue-derived Stem Cell Therapy Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size 2015-2025
2.1.2 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region
2.2 Adipose Tissue-derived Stem Cell Therapy Segment by Type
2.2.1 Autologous Stem Cells
2.2.2 Autologous Stem Cells
2.3 Adipose Tissue-derived Stem Cell Therapy Market Size by Type
2.3.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
2.3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type (2015-2020)
2.4 Adipose Tissue-derived Stem Cell Therapy Segment by Application
2.4.1 Therapeutic Application
2.4.2 Research Application
2.5 Adipose Tissue-derived Stem Cell Therapy Market Size by Application
2.5.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Application (2015-2020)
3 Global Adipose Tissue-derived Stem Cell Therapy by Players
3.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Players
3.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Players (2018-2020)
3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Players (2018-2020)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adipose Tissue-derived Stem Cell Therapy by Regions
4.1 Adipose Tissue-derived Stem Cell Therapy Market Size by Regions
4.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size Growth
4.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size Growth
4.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth
4.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth
5 Americas
5.1 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Countries
5.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type
5.3 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Regions
6.2 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type
6.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Adipose Tissue-derived Stem Cell Therapy by Countries
7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type
7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy by Countries
8.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type
8.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast
10.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast (2021-2025)
10.2 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions
10.2.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Type
10.8 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Application
11 Key Players Analysis
11.1 AlloCure
11.1.1 Company Details
11.1.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 AlloCure News
11.2 Tissue Genesis
11.2.1 Company Details
11.2.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.2.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Tissue Genesis News
11.3 Antria
11.3.1 Company Details
11.3.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.3.3 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Antria News
11.4 Cellleris
11.4.1 Company Details
11.4.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Cellleris News
11.5 Corestem
11.5.1 Company Details
11.5.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Corestem News
11.6 Celgene Corporation
11.6.1 Company Details
11.6.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.6.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Celgene Corporation News
11.7 Mesoblast
11.7.1 Company Details
11.7.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.7.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Mesoblast News
11.8 Cytori Therapeutics
11.8.1 Company Details
11.8.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.8.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Cytori Therapeutics News
11.9 Pluristem Therapeutics
11.9.1 Company Details
11.9.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Pluristem Therapeutics News
11.10 Intrexon
11.10.1 Company Details
11.10.2 Adipose Tissue-derived Stem Cell Therapy Product Offered
11.10.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Intrexon News
11.11 Lonza
11.12 BioRestorative Therapies
11.13 Pluristem Therapeutics
11.14 iXCells Biotechnologies
11.15 Cyagen
11.16 Celltex Therapeutics Corporation
12 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Adipose Tissue-derived Stem Cell Therapy Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Adipose Tissue-derived Stem Cell Therapy Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Autologous Stem Cells
Table 7. Major Players of Allogeneic Stem Cells
Table 8. Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
Table 10. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2015-2020)
Table 12. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2018-2020)
Table 14. Global Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered
Table 15. Adipose Tissue-derived Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions 2015-2020
Table 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Countries (2015-2020)
Table 22. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
Table 24. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2015-2020)
Table 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions (2015-2020)
Table 28. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
Table 30. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2015-2020)
Table 32. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Countries (2015-2020)
Table 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
Table 36. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Adipose Tissue-derived Stem Cell Therapy
Table 45. Key Application and Potential Industries of Adipose Tissue-derived Stem Cell Therapy
Table 46. Key Challenges of Adipose Tissue-derived Stem Cell Therapy
Table 47. Key Trends of Adipose Tissue-derived Stem Cell Therapy
Table 48. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Regions
Table 50. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Application (2021-2025)
Table 54. AlloCure Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 55. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 56. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 57. AlloCure Main Business
Table 58. AlloCure Latest Developments
Table 59. Tissue Genesis Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 60. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 61. Tissue Genesis Main Business
Table 62. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 63. Tissue Genesis Latest Developments
Table 64. Antria Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 65. Antria Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 66. Antria Main Business
Table 67. Antria Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 68. Antria Latest Developments
Table 69. Cellleris Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 70. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 71. Cellleris Main Business
Table 72. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 73. Cellleris Latest Developments
Table 74. Corestem Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 75. Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 76. Corestem Main Business
Table 77. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 78. Corestem Latest Developments
Table 79. Celgene Corporation Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 80. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 81. Celgene Corporation Main Business
Table 82. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 83. Celgene Corporation Latest Developments
Table 84. Mesoblast Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 85. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 86. Mesoblast Main Business
Table 87. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 88. Mesoblast Latest Developments
Table 89. Cytori Therapeutics Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 90. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 91. Cytori Therapeutics Main Business
Table 92. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 93. Cytori Therapeutics Latest Developments
Table 94. Pluristem Therapeutics Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 95. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 96. Pluristem Therapeutics Main Business
Table 97. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 98. Pluristem Therapeutics Latest Developments
Table 99. Intrexon Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 100. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered
Table 101. Intrexon Main Business
Table 102. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue and Gross Margin (2018-2020E)
Table 103. Intrexon Latest Developments
Table 104. Lonza Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 105. BioRestorative Therapies Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 106. Pluristem Therapeutics Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 107. iXCells Biotechnologies Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 108. Cyagen Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
Table 109. Celltex Therapeutics Corporation Details, Company Total Revenue (in $ million), Head Office, Adipose Tissue-derived Stem Cell Therapy Major Market Areas and Its Competitors
List of Figures
Figure 1. Adipose Tissue-derived Stem Cell Therapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2015-2020)
Figure 5. Global Autologous Stem Cells Market Size Growth Rate
Figure 6. Global Allogeneic Stem Cells Market Size Growth Rate
Figure 7. Adipose Tissue-derived Stem Cell Therapy in Therapeutic Application
Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Market: Therapeutic Application (2015-2020) ($ Millions)
Figure 9. Adipose Tissue-derived Stem Cell Therapy in Research Application
Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market: Research Application (2015-2020) ($ Millions)
Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2019
Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions 2015-2020
Figure 13. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 14. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 15. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 16. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2015-2020 ($ Millions)
Figure 17. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Countries in 2019
Figure 18. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2019
Figure 19. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2019
Figure 20. United States Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 21. Canada Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 22. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 23. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions in 2019
Figure 24. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2019
Figure 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2019
Figure 26. China Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 27. Japan Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 28. Korea Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 29. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 30. India Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 31. Australia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 32. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Countries in 2019
Figure 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2019
Figure 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2019
Figure 35. Germany Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 36. France Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 37. UK Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 38. Italy Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 39. Russia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 40. Spain Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Countries in 2019
Figure 42. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2019
Figure 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2019
Figure 44. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 45. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 46. Israel Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 47. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 48. GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 49. Global Adipose Tissue-derived Stem Cell Therapy arket Size Forecast (2021-2025) ($ Millions)
Figure 50. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 51. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 52. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 53. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 54. United States Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 55. Canada Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 56. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 57. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 58. China Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 59. Japan Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 60. Korea Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 61. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 62. India Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 63. Australia Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 64. Germany Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 65. France Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 66. UK Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 67. Italy Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 68. Russia Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 69. Spain Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 70. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 71. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 72. Israel Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 73. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
Figure 74. GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2025 ($ Millions)
